⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30858719 | 0.97 | — | — | |
| SCHEMBL28636550 | 0.97 | CES2 (0.58) | — | |
| SCHEMBL218387 | 0.97 | CES2 (0.58) | — | |
| SCHEMBL217106 | 0.97 | CES2 (0.58) | — | |
| SCHEMBL217428 | 0.97 | CES2 (0.58) | — | |
| SCHEMBL25485911 | 0.97 | CES2 (0.58) | — | |
| SCHEMBL30542352 | 0.97 | CES2 (0.58) | — | |
| SCHEMBL215922 | 0.97 | CES2 (0.58) | — | |
| Cyclohexane Carboxamide SCHEMBL26181 | 0.97 | — | — | |
| SCHEMBL30542351 | 0.97 | CES2 (0.58) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2366 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3717459-B1 | COMPOUNDS | STEP PHARMA S A S (FR) | 2026-01-21 | — | — | EP | claimed |
| EP-4301736-B1 | MACROCYCLIC COMPOUNDS AS PROTEASOME SUBUNIT BETA TYPE-5 INHIBITORS | LEAD DISCOVERY CENTER GMBH (DE) | 2025-10-08 | — | — | EP | claimed |
| EP-4598327-A1 | PEROVSKITE SOLAR CELL AND PREPARATION METHOD THEREFOR, AND ELECTRIC DEVICE | Contemporary Amperex Technology (Hong Kong) Limited (HK) | 2025-08-06 | — | — | EP | claimed |
| US-20250234769-A1 | PEROVSKITE SOLAR CELL AND PREPARATION METHOD THEREOF, AND ELECTRICAL APPARATUS | CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) | 2025-07-17 | — | — | US | claimed |
| US-12247036-B2 | Tricyclic compounds for the treatment of cancer | HOFFMANN-LA ROCHE INC. (US) | 2025-03-11 | — | — | US | claimed |
| WO-2025043349-A1 | PYRIMIDOPYRIDONE AND PTERIDONE DERIVATIVES AS INHIBITORS OF THE GCN2 KINASE, COMPOSITIONS AND USES THEREOF | ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) | 2025-03-06 | — | — | WO | claimed |
| EP-4499097-A1 | METHODS OF TREATING A SUBJECT FOR POST-TREATMENT LYME DISEASE (PTLD) AND COMPOSITIONS FOR USE IN THE SAME | IncellDx, Inc. (US) | 2025-02-05 | — | — | EP | claimed |
| US-20240415819-A1 | MACROCYCLIC COMPOUNDS AS PROTEASOME SUBUNIT BETA TYPE-5 INHIBITORS | QLi5 Therapeutics AG (DE) | 2024-12-19 | — | — | US | claimed |
| US-20240417410-A1 | TRICYCLIC COMPOUNDS FOR THE TREATMENT OF CANCER | HOFFMANN-LA ROCHE INC. (US) | 2024-12-19 | — | — | US | claimed |
| EP-3740481-B9 | DIHYDROBENZOFURAN AND INDEN ANALOGS AS CARDIAC SARCOMERE INHIBITORS | CYTOKINETICS INC (US) | 2024-10-23 | — | — | EP | claimed |
| JP-2002512230-A | — | — | 2002-04-23 | — | — | JP | claimed |
| CN-1344266-A | Novel compounds | ASTRAZENECA AB (SE) | 2002-04-10 | — | — | CN | claimed |
| US-6245714-B1 | HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2001-06-12 | — | — | US | claimed |
| EP-1071668-A1 | 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS | Du Pont Pharmaceuticals Company (US) | 2001-01-31 | — | — | EP | claimed |
| EP-1022272-A1 | SUBSTITUTED FUSED HETEROCYCLIC COMPOUNDS | Sankyo Company Limited (JP) | 2000-07-26 | — | — | EP | claimed |
| WO-1999054308-A1 | 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS | DU PONT PHARMACEUTICALS COMPANY (US) | 1999-10-28 | — | — | WO | claimed |
| CN-1220663-A | Substituted phenyl uracils | BAYER AG (DE) | 1999-06-23 | — | — | CN | claimed |
| EP-0247199-A1 | SYNTHETIC ROUTES TO CYCLOPENTANECARBOXYLIC ACID DERIVATIVES | KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JP) | 1987-12-02 | — | — | EP | claimed |
| WO-1987003278-A2 | SYNTHETIC ROUTES TO CYCLOPENTANECARBOXYLIC ACID DERIVATIVES | SCHERING AG (DE) | 1987-06-04 | — | — | WO | claimed |
| WO-1987003278-A1 | SYNTHETIC ROUTES TO CYCLOPENTANECARBOXYLIC ACID DERIVATIVES | SCHERING AKTIENGESELLSCHAFT BERLIN UND BERGKAMEN (DE) | 1987-06-04 | — | — | WO | claimed |